Research Feeds

Our team reviews, analyzes, and summarizes the latest health and nutrition studies to help you be healthier. Updated daily.

Premium Content

We are an entirely self-funded, with no third-party ads or ties to food and supplement companies.

The study explored intermittent clomiphene citrate treatment (CT) for women with COS who were resistant to standard C treatment. CT showed an 80.8% response rate, offering an effective and safer alternative to gonadotropin therapy with no risk of HSS or multiple pregnancies.

Category View Feed View
Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.